An innovative cancer treatment, considered a “cure” for the disease, could make tumors disappear, according to an experimental study. This approach is seen as a remarkable breakthrough in some brain cancer patients – experts say it could be available within the next five years.

Statistics say that more than 3,00,000 cases of brain tumors occur every year worldwide and it continues to be a matter of grave concern to the international medical community. Although some brain tumors are benign, many invade the normal brain and develop into fatal brain cancer. According to doctors, only one in ten patients with this deadly disease remains alive even a decade after being diagnosed. Because brain cancer spreads so quickly, the prognosis is often bleak, lacking treatment it cannot be successfully fought.

However, new treatment plans combining the drug ipilimumab with surgery, chemotherapy or radiotherapy – are seen as a game-changer for many sufferers.

How does ipilimumab work?

Also known as Yervoy as a brand name, ipilimumab treats many types of cancer And works as a monoclonal antibody that attaches to the CTLA-4 protein on T cells, a type of immune cell. It prevents cancer cells from suppressing the immune system, allowing the immune system to attack and destroy the cancer cells. Ipilimumab is administered as a drip into the bloodstream and is used to treat skin cancer – it is given first to shrink the tumor.

Experts behind the treatment say the drug helps patients’ own immune systems find cancer cells and destroy them. Patients are also offered surgery to remove tumor remnants along with other treatment methods. So far, doctors say only a small number of patients have been offered the innovative treatment protocol, invented by brain cancer specialist Dr. Paul Mulholland of University College, London.

According to experts, this immunotherapy drug can actually become a cure for brain cancer.

Brain cancer is difficult to treat

Experts say brain cancer is difficult to treat because many drugs are not able to cross the blood-brain barrier – a protective wall of cells that acts as a filter and protects the brain from harmful substances and germs in the blood. Protects those who can cause damage.

However, drugs like ipilimumab don’t have that problem, because according to Dr. Mulholland, they work by helping your body’s immune system T-cells detect and attack tumors.

Dr. Mulholland says researchers are now planning an upcoming clinical trial that will focus on introducing the drug to patients as soon as possible after they are diagnosed. “What we want to do is to cure patients of the disease before chemotherapy and radiotherapy weaken the body,” he said. “Essentially we’re saying, let’s protect the immune system so it’s at its best at fighting cancer.”

Although Dr. Mulholland is optimistic, many other experts have urged caution on the treatment’s success, as it has only been used on a small number of patients so far, and efficacy will not be known until the drugs are on the market. Would have come. On a large scale for the treatment of brain cancer.

Clinical trials are scheduled to begin next year.

Get the latest news live on Times Now with breaking news and top headlines from around the world.